These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30779584)

  • 21. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
    Oishi S; Kuroyanagi T; Kubo T; Montpas N; Yoshikawa Y; Misu R; Kobayashi Y; Ohno H; Heveker N; Furuya T; Fujii N
    J Med Chem; 2015 Jul; 58(13):5218-25. PubMed ID: 26042340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
    Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
    J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemokine receptor CXCR7 influences prognosis in human glioma in an IDH1-dependent manner.
    Birner P; Tchorbanov A; Natchev S; Tuettenberg J; Guentchev M
    J Clin Pathol; 2015 Oct; 68(10):830-4. PubMed ID: 26109200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose tissue-derived mesenchymal stem cells in vitro.
    Li Q; Zhang A; Tao C; Li X; Jin P
    Biochem Biophys Res Commun; 2013 Nov; 441(3):675-80. PubMed ID: 24184476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway.
    Xu D; Li R; Wu J; Jiang L; Zhong HA
    Curr Top Med Chem; 2016; 16(13):1441-51. PubMed ID: 26369824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting chemokine receptor CXCR7 inhibits glioma cell proliferation and mobility.
    Liu Y; Carson-Walter E; Walter KA
    Anticancer Res; 2015 Jan; 35(1):53-64. PubMed ID: 25550535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration.
    Hunger C; Ödemis V; Engele J
    Exp Cell Res; 2012 Oct; 318(17):2178-90. PubMed ID: 22766125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atorvastatin inhibits CXCR7 induction to reduce macrophage migration.
    Ma W; Liu Y; Wang C; Zhang L; Crocker L; Shen J
    Biochem Pharmacol; 2014 May; 89(1):99-108. PubMed ID: 24582769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
    Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
    PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR7 agonists inhibit the function of CXCL12 by down-regulation of CXCR4.
    Uto-Konomi A; McKibben B; Wirtz J; Sato Y; Takano A; Nanki T; Suzuki S
    Biochem Biophys Res Commun; 2013 Feb; 431(4):772-6. PubMed ID: 23333329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR7/CXCR4 heterodimer-induced histone demethylation: a new mechanism of colorectal tumorigenesis.
    Song ZY; Wang F; Cui SX; Gao ZH; Qu XJ
    Oncogene; 2019 Feb; 38(9):1560-1575. PubMed ID: 30337690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells.
    Gentilini A; Caligiuri A; Raggi C; Rombouts K; Pinzani M; Lori G; Correnti M; Invernizzi P; Rovida E; Navari N; Di Matteo S; Alvaro D; Banales JM; Rodrigues P; Raschioni C; Donadon M; Di Tommaso L; Marra F
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2246-2256. PubMed ID: 31059778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena.
    Han B; McPhail KL; Ligresti A; Di Marzo V; Gerwick WH
    J Nat Prod; 2003 Oct; 66(10):1364-8. PubMed ID: 14575438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR7 silencing inhibits the migration and invasion of human tumor endothelial cells derived from hepatocellular carcinoma by suppressing STAT3.
    Wu Y; Tian L; Xu Y; Zhang M; Xiang S; Zhao J; Wang Z
    Mol Med Rep; 2018 Aug; 18(2):1644-1650. PubMed ID: 29901083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3).
    Sekiguchi H; Kuroyanagi T; Rhainds D; Kobayashi K; Kobayashi Y; Ohno H; Heveker N; Akaji K; Fujii N; Oishi S
    J Med Chem; 2018 Apr; 61(8):3745-3751. PubMed ID: 29608300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells.
    Hartmann TN; Grabovsky V; Pasvolsky R; Shulman Z; Buss EC; Spiegel A; Nagler A; Lapidot T; Thelen M; Alon R
    J Leukoc Biol; 2008 Oct; 84(4):1130-40. PubMed ID: 18653785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frontline Science: CXCR7 mediates CD14
    Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
    J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new malyngamide from the marine cyanobacterium Moorea producens.
    Jiang W; Zhou W; Othman R; Uchida H; Watanabe R; Suzuki T; Sakamoto B; Nagai H
    Nat Prod Res; 2018 Jan; 32(1):97-104. PubMed ID: 28595450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.